Novo Nordisk A/S

NVO

$50.88

Name : Novo Nordisk A/S

Sector : Healthcare

Industry: Drug Manufacturers - General

Mark. Cap: $226,084,241,408.00

EPSttm : 3.68

Novo Nordisk A/S

$50.88

0.66%

$0.34

Float Short %

0.85

Margin Of Safety %

Put/Call OI Ratio

0.73

EPS Next Q Diff

EPS Last/This Y

19.46

EPS This/Next Y

-1.34

Price

50.88

Target Price

60.03

Analyst Recom

2.24

Performance Q

-14.01

Relative Volume

0.54

Beta

0.66

Ticker: NVO

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-01	NVO	48.44	0.72	0.46	1677518
2025-12-02	NVO	47.48	0.72	0.38	1698555
2025-12-03	NVO	47.63	0.71	0.35	1730780
2025-12-04	NVO	48	0.71	0.82	1747737
2025-12-05	NVO	47.93	0.71	0.57	1758528
2025-12-08	NVO	46.8	0.71	0.45	1675450
2025-12-09	NVO	46.5	0.72	0.48	1691857
2025-12-10	NVO	49	0.72	0.39	1703385
2025-12-11	NVO	50.28	0.71	0.25	1720717
2025-12-12	NVO	50.18	0.71	0.45	1728630
2025-12-15	NVO	50.31	0.69	0.46	1678676
2025-12-16	NVO	48.96	0.68	0.43	1692822
2025-12-17	NVO	47.84	0.69	0.20	1699522
2025-12-18	NVO	47.62	0.68	0.64	1704541
2025-12-19	NVO	48.1	0.68	0.72	1719744
2025-12-22	NVO	48.1	0.71	0.28	1384365
2025-12-23	NVO	51.63	0.69	0.28	1437548
2025-12-26	NVO	52.39	0.72	0.29	1526521
2025-12-29	NVO	51.46	0.73	0.39	1454651
2025-12-30	NVO	51.24	0.73	0.42	1466616
2025-12-31	NVO	50.88	0.73	0.72	1476410
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-01	NVO	48.43	-7.5	-1167.5	23.10
2025-12-02	NVO	47.43	-7.4	-1414.2	23.11
2025-12-03	NVO	47.57	-7.4	-952.4	23.11
2025-12-04	NVO	48.00	-7.5	-1359.5	23.11
2025-12-05	NVO	47.86	-7.5	-1416.3	23.08
2025-12-08	NVO	46.77	-7.5	-	23.26
2025-12-09	NVO	46.36	-7.5	-2100.5	23.26
2025-12-10	NVO	49.08	-8.3	-1289.4	23.03
2025-12-11	NVO	50.28	-8.3	-991.1	23.03
2025-12-12	NVO	50.17	-8.3	-1691.7	23.03
2025-12-15	NVO	50.37	-8.3	-1704.1	23.03
2025-12-16	NVO	50.37	-8.3	-1959.4	23.03
2025-12-17	NVO	47.77	-8.3	-1784.4	23.03
2025-12-18	NVO	47.62	-8.3	-2197.3	23.03
2025-12-19	NVO	48.11	-8.3	-1765.0	23.03
2025-12-22	NVO	48.12	-8.3	-2112.2	23.03
2025-12-23	NVO	51.72	-8.3	-295.6	23.03
2025-12-26	NVO	52.41	-8.3	-1962.7	23.03
2025-12-29	NVO	51.45	-8.3	-2275.2	23.03
2025-12-30	NVO	51.20	-8.3	-1787.9	23.03
2025-12-31	NVO	50.88	-8.3	-1888.4	23.03
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-01	NVO	0	-1.57	0.82
2025-12-02	NVO	0	-1.57	0.82
2025-12-03	NVO	0	-1.57	0.82
2025-12-04	NVO	0	-1.57	0.82
2025-12-05	NVO	0	-1.57	0.82
2025-12-08	NVO	0	-1.58	0.82
2025-12-09	NVO	0	-1.58	0.82
2025-12-10	NVO	0	-1.58	0.88
2025-12-11	NVO	0	-1.58	0.88
2025-12-12	NVO	0	-1.58	0.88
2025-12-15	NVO	0	-1.44	0.88
2025-12-16	NVO	0	-1.44	0.88
2025-12-17	NVO	0	-1.44	0.88
2025-12-18	NVO	0	-1.44	0.88
2025-12-19	NVO	0	-1.44	0.88
2025-12-22	NVO	0	-1.39	0.88
2025-12-23	NVO	0	-1.39	0.88
2025-12-26	NVO	0	-1.39	0.85
2025-12-29	NVO	0	-1.53	0.85
2025-12-30	NVO	0	-1.53	0.85
2025-12-31	NVO	0	-1.53	0.85
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.02

Avg. EPS Est. Current Quarter

5.82

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-1.53

Beta

0.66

Average Sales Estimate Current Quarter

77280

Average Sales Estimate Next Quarter

76155

Fair Value

51.83

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

65.7

Max Drawdown 5-Year %

-68.5

Target Price

60.03

P/E

14.82

Forward P/E

14.46

PEG

2.61

P/S

3.67

P/B

8.45

P/Free Cash Flow

17.14

EPS

3.43

Average EPS Est. Cur. Y

23.03

EPS Next Y. (Est.)

21.69

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

32.76

Relative Volume

0.54

Return on Equity vs Sector %

33.8

Return on Equity vs Industry %

24.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.07

EBIT Estimation

-1888.4

Novo Nordisk A/S

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 78554

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

stock quote shares NVO – Novo Nordisk A/S Stock Price stock today

news today NVO – Novo Nordisk A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch NVO – Novo Nordisk A/S yahoo finance google finance

stock history NVO – Novo Nordisk A/S invest stock market

stock prices NVO premarket after hours

ticker NVO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NVO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y